BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9527265)

  • 1. Sentinel node biopsy in breast cancer.
    Barnwell JM; Arredondo MA; Kollmorgen D; Gibbs JF; Lamonica D; Carson W; Zhang P; Winston J; Edge SB
    Ann Surg Oncol; 1998 Mar; 5(2):126-30. PubMed ID: 9527265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sentinel node biopsy in breast cancer and primary tumor dimension].
    Basta P; Tomaszewska R; Pityński K; Opławski M; Basta A
    Ginekol Pol; 2003 Sep; 74(9):666-70. PubMed ID: 14674105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group.
    Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM
    Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
    Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
    Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
    Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
    Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer.
    Ruano R; Ramos M; Garcia-Talavera JR; Serrano E; De Arriba A; Gonzalez-Orus J; Iglesias M; Macias MC
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1299-304. PubMed ID: 18274744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P; Ibis E; Aras G; Cam R; Küçük NO
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of sentinel lymph node in patients with early stage breast cancer].
    Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
    Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
    Veronesi U; De Cicco C; Galimberti VE; Fernandez JR; Rotmensz N; Viale G; Spano G; Luini A; Intra M; Veronesi P; Berrettini A; Paganelli G
    Ann Oncol; 2007 Mar; 18(3):473-8. PubMed ID: 17164229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.